New antipsychotics for the treatment of schizophrenia

Authors

  • Hélio Elkis International Psychopharmacology Algorithm Project
  • Mário Rodrigues Louzã Universidade de Würzburg

DOI:

https://doi.org/10.1590/S0101-60832007000800009

Keywords:

Antipsychotics, neuroleptics, asenapine, ACP-103, bifeprunox, paliperidone, long acting injectable risperidone, sertindole

Abstract

BACKGROUND: The second generation antipsychotics represent the great achievement in the treatment of schizophrenia of the last decades. However in the last years some new antipsychotics were synthesized and such new compounds may represent great perspectives for the field of the treatment of schizophrenia. Some of these compounds are in use while others are still on evaluation through clinical trials. OBJECTIVE: Summarize the current knowledge of new antipsychotics. METHODS: PubMed search as well literature provided by the manufactures. RESULTS AND CONCLUSIONS: We present the main pharmacological characteristics as well as profiles of efficacy, security and tolerability of the following compounds: Asenapine, ACP-103, Bifeprunox, Paliperidone, Long Acting Injectable Risperidone and Sertindole.

Downloads

Download data is not yet available.

Downloads

Published

2007-01-01

Issue

Vol. 34 No. supl.2 (2007)

Section

Reviews of Literature

License

Once accepted for publication, the manuscript becomes permanent property of the Archives of Clinical Psychiatry. This copyright transfer subsumes exclusive and unlimited entitlement of the Archives of Clinical Psychiatry to publish and distribute the full contents of articles in whichever publishing medium, including press and electronic media, in Brazil and abroad.

Manuscripts are accepted with the understanding that the Editor and the editorial staff have the right to make revisions aimed at greater conciseness, clarity, and conformity with Journal style, of course without changing its content.

How to Cite

New antipsychotics for the treatment of schizophrenia . (2007). Archives of Clinical Psychiatry, 34(supl.2), 193-197. https://doi.org/10.1590/S0101-60832007000800009